Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
Locally advanced nasopharyngeal carcinoma patients(UICC7th stageIII to IVb) will receive
either cisplatin plus 5-fluorouracil (PF) or docetaxel plus cisplatin and 5-fluorouracil(TPF)
neoadjuvant chemotherapy with concurrent chemoradiation.
Phase:
Phase 3
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Collaborators:
Second Affiliated Hospital, School of Medicine, Zhejiang University Sir Run Run Shaw Hospital Wenzhou Medical University Zhejiang Provincial People's Hospital Zhejiang Provincial People’s Hospital Zhejiang University